[1]
“Trial of Immunotherapy in HIV Patients: Our Experience with the Immuno-Modulator Dithiodinicotinic Acid (CPDS) in 34 Congolese Patients”, GJMR, vol. 17, no. K2, pp. 19–26, Jan. 2017, Accessed: Jan. 31, 2026. [Online]. Available: https://medicalresearchjournal.org/index.php/GJMR/article/view/1291